[
  {
    "table_index": 1,
    "headers": [],
    "rows": [
      [
        "End Note"
      ],
      [
        "Procite"
      ],
      [
        "Reference Manager"
      ]
    ],
    "row_count": 3,
    "column_count": 1
  },
  {
    "table_index": 2,
    "headers": [],
    "rows": [
      [
        "Hepatic",
        "• Asymptomatic hepatomegaly • Isolated splenomegaly • Persistently elevated serum aminotransferase activity (AST, ALT) • Fatty liver • Acute hepatitis, varying severity including acute liver injury (ALI) • Resembling autoimmune hepatitis • Cirrhosis—compensated or decompensated • Acute liver failure"
      ],
      [
        "Neurological",
        "• Dysarthria • Movement disorders (tremor, involuntary movements) • Pseudobulbar palsy • Drooling, transfer dysphagia • Rigid dystonia • Dysautonomia • Seizures • Sleep disorders, insomnia"
      ],
      [
        "Psychiatric",
        "• Depression • Bipolar disorder/bipolar spectrum • Neurotic behaviors • Personality changes • Psychosis"
      ],
      [
        "Other systems",
        "• Eye: Kayser–Fleischer rings, sunflower cataracts • Renal abnormalities: aminoaciduria and nephrolithiasis • Skeletal abnormalities: premature osteoporosis and arthritis • Cardiomyopathy, dysrhythmias • Pancreatitis • Hypoparathyroidism • Infertility, repeated miscarriages"
      ]
    ],
    "row_count": 4,
    "column_count": 2
  },
  {
    "table_index": 3,
    "headers": [
      "Disorder",
      "Gene",
      "Serum ceruloplasmin",
      "Hepatic Cu",
      "24‐h basal urinary Cu",
      "Possible mechanism(s)",
      "Typea"
    ],
    "rows": [
      [
        "Aceruloplasminemia",
        "CP",
        "Absent",
        "Normal; ↑Fe",
        "Normal",
        "No production of ceruloplasmin",
        "Clinical"
      ],
      [
        "MDR3 deficiency",
        "ABCB4",
        "Normal",
        "",
        "May be ↑",
        "Copper retention due to cholestasis",
        "Clinical"
      ],
      [
        "MEDNIK syndromeb",
        "AP1S1",
        "Very low",
        "May be ↑",
        "↑ (2.5 μmol /24‐h)",
        "Protein production + metal (Cu) excretion abnormality",
        "Mechanistic"
      ],
      [
        "Mn retention–1c",
        "SLC30A10",
        "Normal",
        "Slightly ↑",
        "??",
        "Hepatic Mn excretion abnormality",
        "Mechanistic"
      ],
      [
        "Mn retention–2c",
        "SLC39A14",
        "Not reported",
        "Hepatic Mn uptake abnormality",
        "Mechanistic"
      ],
      [
        "Nieman–Pick type Cd",
        "NPC1,NPC2",
        "Low or slightly low",
        "Mildly ↑ (between 100 and 250 μg/g dry weight)",
        "Normal",
        "Defective interaction with ATP7B",
        "Mechanistic"
      ],
      [
        "PGM1–CDG",
        "PGM1",
        "Low",
        "Mildly ↑ (between 50 and 250 μg/g dry weight)",
        "Normal",
        "(Golgi dysfunction)",
        "Clinical, mechanistic"
      ],
      [
        "CCDC115–CGDe",
        "CCDC115",
        "Low or very low",
        "Slightly ↑",
        "Normal or mildly ↑",
        "Abnormality in protein production pathway affecting ATP7B function (Golgi dysfunction)",
        "Clinical, mechanistic"
      ],
      [
        "TMEM119–CDGe",
        "TMEM199",
        "Low",
        "Not reported",
        "Normal or mildly ↑",
        "(Golgi dysfunction)",
        "Clinical, mechanistic"
      ]
    ],
    "row_count": 9,
    "column_count": 7
  },
  {
    "table_index": 4,
    "headers": [
      "Neurological manifestations at onset",
      "% of patients",
      "Treatments"
    ],
    "rows": [
      [
        "Dysarthria",
        "46–97",
        "Speech therapy"
      ],
      [
        "Gait abnormality/ataxia/cerebellar",
        "28–75",
        "Physical therapy, assistive device"
      ],
      [
        "Dystonia",
        "38–69",
        "Trihexyphenidyl, botulinum toxin (for focal symptoms), clonazepam"
      ],
      [
        "Parkinsonism",
        "12–58",
        "Carbidopa/levodopa, dopamine agonist"
      ],
      [
        "Postural tremor",
        "55",
        "Primidone, propranolol, clonazepam"
      ],
      [
        "Dysphagia",
        "50",
        "Swallow therapy, thickeners"
      ],
      [
        "Chorea/athetosis",
        "6–30",
        "Neuroleptics, VMAT2 inhibitors"
      ],
      [
        "Seizures",
        "6–28",
        "Anticonvulsants"
      ],
      [
        "Rest tremor",
        "4",
        "Carbidopa/levodopa, dopamine agonist"
      ]
    ],
    "row_count": 9,
    "column_count": 3
  },
  {
    "table_index": 5,
    "headers": [],
    "rows": [
      [
        "Nonselective renal protein loss"
      ],
      [
        "Protein‐losing enteropathy"
      ],
      [
        "Severe chronic liver disease with global hepatic synthetic deficit"
      ],
      [
        "Neurological disorders (cervical dystonia)"
      ],
      [
        "Absolute copper deficiency"
      ],
      [
        "Improper formulation of TPN omitting copper"
      ],
      [
        "After gastric or bariatric surgery"
      ],
      [
        "Chronic Ingestion of zinc in excess"
      ],
      [
        "Menkes disease"
      ],
      [
        "Aceruloplasminemia"
      ],
      [
        "MEDNIK syndrome (AP1S1disorder)"
      ],
      [
        "AP1B1disorder"
      ],
      [
        "Congenital glycosylation disorder"
      ],
      [
        "PGM1‐CDG"
      ],
      [
        "CCDC115‐CGD"
      ],
      [
        "TMEM119‐CDG"
      ],
      [
        "Niemann‐Pick type C"
      ]
    ],
    "row_count": 17,
    "column_count": 1
  },
  {
    "table_index": 6,
    "headers": [
      "",
      "URL",
      "Comments"
    ],
    "rows": [
      [
        "Public domain databases"
      ],
      [
        "ClinVar",
        "https://www.ncbi.nlm.nih.gov/clinvar/",
        "National Center for Biotechnology Information (NCBI)"
      ],
      [
        "gnomAD",
        "https://gnomad.broadinstitute.org/",
        ""
      ],
      [
        "VarSome",
        "https://landing.varsome.com/varsome‐clinical",
        ""
      ],
      [
        "Proprietary databases"
      ],
      [
        "Human Gene Mutation Database",
        "http://www.hgmd.org",
        "University of Cardiff83"
      ],
      [
        "WilsonGen",
        "https://clingen.igib.res.in/WilsonGen/",
        "CSIR Institute of Genomics and Integrative Biology, Delhi84"
      ],
      [
        "University of Alberta Wilson Disease Mutation Database",
        "(Previously)www.medgen.med.ualberta.ca/database.html",
        "Limited or no access at the present time85"
      ]
    ],
    "row_count": 8,
    "column_count": 3
  },
  {
    "table_index": 7,
    "headers": [
      "Type of problem",
      "Specific issues",
      "Action"
    ],
    "rows": [
      [
        "Accuracy of laboratory data",
        "Serum ceruloplasmin—known confounders",
        "See ES‐"
      ],
      [
        "",
        "24‐h urinary copper—incomplete collection or contamination",
        "• Confirm technical adequacy of assay • Check creatinine level • Repeat testing"
      ],
      [
        "",
        "Liver [Cu]—was specimen large enough? Stored properly?",
        "Check report and/or discuss with pathologist."
      ],
      [
        "",
        "Competence/completeness of genetic analysis",
        "• Review protocols • Consult clinical geneticist • Confirm trans (not cis) mutations"
      ],
      [
        "Adequacy of clinical assessment",
        "Neurological assessment",
        "• Expert review for specifying relevant findings • Brain MRI"
      ],
      [
        "",
        "Kayser–Fleischer rings",
        "Repeat exam or optical tomography to determine whether present or not."
      ],
      [
        "",
        "Psychiatric assessment (only implied in algorithms)",
        "Expert consultation/review"
      ],
      [
        "Data available but not accounted for in algorithms",
        "Liver biochemistries",
        "• Normal LFTs would likely preclude a liver biopsy. • Abnormal LFTs support WD or some other liver disorder: biopsy may be performed."
      ],
      [
        "",
        "Liver histology",
        "• Findings may support WD or provide basis for alternative diagnosis. • Consider examining ultrastructure (by EM) as findings may support WD, notably in children."
      ],
      [
        "Emerging problems not well accounted for in algorithms",
        "Hepatic Cu <250 μg/g dry weight but above suggested revisions of that threshold (e.g., >75 μg/g dry weight) and well above normal",
        "• Reevaluate, with genetic analysis if not yet performed. • Treatment trial."
      ],
      [
        "",
        "Only one mutation found, but along with a VUS",
        "• Repeat clinical/biochemical evaluation in 6–12 months or until clear diagnosis reached. • In silico assessment of VUS."
      ],
      [
        "",
        "Screening reveals affected infant/toddler who is entirely healthy",
        "Reevaluate every 6 months: plan to start treatment at 3 years‐old unless earlier evidence of organ damage."
      ]
    ],
    "row_count": 12,
    "column_count": 3
  },
  {
    "table_index": 8,
    "headers": [
      "Parameters",
      "Points"
    ],
    "rows": [
      [
        "Specific clinical features",
        ""
      ],
      [
        "Kayser–Fleischer rings (by slit‐lamp examination)",
        ""
      ],
      [
        "Present",
        "2"
      ],
      [
        "Absent",
        "0"
      ],
      [
        "Neuropsychiatric symptoms suggestive of WD (or typical features on brain MRIa)",
        ""
      ],
      [
        "Present",
        "2"
      ],
      [
        "Absent",
        "0"
      ],
      [
        "Coombs‐negative (nonimmune) hemolytic anemia (plus high serum copper)",
        ""
      ],
      [
        "Present",
        "1"
      ],
      [
        "Absent",
        "0"
      ],
      [
        "Laboratory tests",
        ""
      ],
      [
        "24‐h urinary copper excretion (in the absence of acute hepatitis)—ULN modifiedb",
        ""
      ],
      [
        "Normal",
        "0"
      ],
      [
        "1–2× ULN",
        "1"
      ],
      [
        ">2× ULN",
        "2"
      ],
      [
        "Normal but >500 μg/day 1 day after challenge with 2× 500 mgd‐penicillamine (see notec)",
        "2"
      ],
      [
        "Liver copper quantitatived",
        ""
      ],
      [
        "Normal (ULN = 50 μg/g dry weight)",
        "−1"
      ],
      [
        "Up to 5× ULN",
        "1"
      ],
      [
        ">5× ULN",
        "2"
      ],
      [
        "Rhodanine‐positive hepatocytes (only if quantitative copper measurement not available)",
        ""
      ],
      [
        "Absent",
        "0"
      ],
      [
        "Present",
        "1"
      ],
      [
        "Serum ceruloplasmin (nephelometric assay, LLN = 20 mg/dle)",
        ""
      ],
      [
        "Normal",
        "0"
      ],
      [
        "10–20",
        "1"
      ],
      [
        "<10",
        "2"
      ],
      [
        "Mutation analysis (ATP7B)",
        ""
      ],
      [
        "Disease‐causing mutations on both chromosomes",
        "4"
      ],
      [
        "Disease‐causing mutation on one chromosome",
        "1"
      ],
      [
        "No disease‐causing mutation detected",
        "0"
      ],
      [
        "Total score (not available: scores 0)",
        ""
      ],
      [
        "Assessment of the WD‐diagnosis scoref"
      ],
      [
        "4 or more: Diagnosis of Wilson disease highly likely"
      ],
      [
        "2–3: Diagnosis of Wilson disease probable, do more investigations"
      ],
      [
        "0–1: Diagnosis of Wilson disease unlikely"
      ]
    ],
    "row_count": 36,
    "column_count": 2
  },
  {
    "table_index": 9,
    "headers": [
      "Points assigned",
      "0",
      "1",
      "2",
      "3",
      "4"
    ],
    "rows": [
      [
        "Bilirubin, mg/dl (μmol/L)",
        "0–5.8 (0‐100)",
        "5.9–8.7 (101‐150)",
        "8.8–11.7 (151‐200)",
        "11.8–17.5 (201‐300)",
        ">17.5 (>300)"
      ],
      [
        "INR",
        "0–1.29",
        "1.3–1.6",
        "1.7–1.9",
        "2.0–2.4",
        "≥2.5"
      ],
      [
        "AST, IU/L",
        "0–100",
        "101–150",
        "151–200",
        "201–300",
        ">300"
      ],
      [
        "WBC (×106/ml)",
        "0–6.7",
        "6.8–8.3",
        "8.4–10.3",
        "10.4–15.3",
        "≥15.4"
      ],
      [
        "Albumin, mg/dl",
        ">4.5",
        "3.4–4.4",
        "2.5–3.3",
        "2.1–2.4",
        "≤2.0"
      ]
    ],
    "row_count": 5,
    "column_count": 6
  },
  {
    "table_index": 10,
    "headers": [
      "Drug",
      "Mode of action",
      "Neurological worsening",
      "Side effects",
      "Comments"
    ],
    "rows": [
      [
        "d‐Penicillamine",
        "General chelator induces renal excretion of copper",
        "10%–20% during initial phase of treatment",
        "• Fever, rash, proteinuria, lupus‐like reaction • Aplastic anemia • Leukopenia • Thrombocytopenia • Nephrotic syndrome • Degenerative changes in skin • Elastosis perforans serpiginosa • Serous retinitis • Hepatotoxicity • Colitis",
        "Reduce dose for surgery to promote wound‐healing and during pregnancy"
      ],
      [
        "Trientine",
        "General chelator induces renal excretion of copper",
        "10%–15% during initial phase of treatment",
        "• Gastritis • Aplastic anemia rare • Sideroblastic anemia • Colitis",
        "Reduce dose for surgery to promote wound‐healing and during pregnancy"
      ],
      [
        "Zinc",
        "Metallothionein inducer, blocks intestinal copper absorption",
        "Can occur during initial phase of treatment",
        "• Gastritis • Biochemical pancreatitis • Zinc accumulation • Possible changes in immune function",
        "No dosage reduction for surgery or pregnancy"
      ]
    ],
    "row_count": 3,
    "column_count": 5
  },
  {
    "table_index": 11,
    "headers": [
      "",
      "Treatment initiationa",
      "Maintenance treatment",
      "Overtreatment",
      "Treatment failure on chronic therapy (nonadherence, drug failure)"
    ],
    "rows": [
      [
        "d‐Penicillamine",
        "Increases",
        "~200–500 (≈3–8 μmol/24‐h)",
        "5–15",
        "Trend to normalb",
        "↓",
        "<100",
        "<5",
        "↓↓CPN, ↓↓Cu;",
        ">500 (previously in range)c",
        ">25",
        "↑"
      ],
      [
        "sideroblastic anemia; ↓WBC;"
      ],
      [
        "↑Fe indices"
      ],
      [
        "Trientine",
        "Increases",
        "~150–500 (≈2.4–8 μmol/24‐h)",
        "5–15",
        "Trend to normalb",
        "↓",
        "<100",
        "<5",
        "↓↓CPN, ↓↓Cu;",
        ">500 (previously in range)c",
        ">25",
        "↑"
      ],
      [
        "sideroblastic anemia; ↓WBC;"
      ],
      [
        "↑Fe indices;"
      ],
      [
        "Zinc",
        "No change, then ↓",
        "<100 (<1.6 μmol/24‐h)",
        "5–15",
        "Trend to normalb",
        "↓",
        "<20",
        "<5",
        "↓↓CPN, ↓↓Cu;",
        ">100 (previously normal/near‐normal)",
        ">25",
        "↑"
      ],
      [
        "sideroblastic anemia; ↓WBC;"
      ],
      [
        "↑Fe indices;"
      ]
    ],
    "row_count": 9,
    "column_count": 5
  },
  {
    "table_index": 12,
    "headers": [
      "First author, year of publication",
      "Place",
      "Time period",
      "n",
      "Population",
      "Indication",
      "Follow‐up, yrs",
      "Patient survival, %",
      "Graft survival, %"
    ],
    "rows": [
      [
        "Schilsky, 199488",
        "USA",
        "–",
        "55 (62 LT)",
        "–",
        "–",
        "33",
        "21",
        "1",
        "2.5",
        "79",
        "–",
        "–",
        "–",
        "",
        ""
      ],
      [
        "Eghtesad, 199989",
        "USA",
        "1971–1993",
        "45 (56 LT)",
        "26",
        "16",
        "15",
        "30",
        "0",
        "5",
        "–",
        "73",
        "69",
        "–",
        "58",
        "54"
      ],
      [
        "Emre, 200190",
        "USA",
        "1988–2000",
        "17 (21 LT)",
        "14",
        "3",
        "6",
        "11",
        "0",
        "5.3",
        "88",
        "–",
        "–",
        "62",
        "–",
        "–"
      ],
      [
        "Sutcliffe, 200391",
        "UK",
        "1988–2000",
        "24 (25 LT)",
        "–",
        "–",
        "–",
        "8",
        "–",
        "87",
        "–",
        "–",
        "87",
        "–"
      ],
      [
        "Wang, 200592",
        "",
        "2001–2003",
        "22",
        "3",
        "19",
        "20",
        "2",
        "9",
        "1.5",
        "95",
        "–",
        "–",
        "95",
        "–",
        "–"
      ],
      [
        "Medici, 200593",
        "Italy",
        "1985–2000",
        "37 (41 LT)",
        "–",
        "–",
        "8",
        "29",
        "0",
        "–",
        "–",
        "75",
        "60",
        "–",
        "70",
        "47"
      ],
      [
        "Sevmis, 200894",
        "",
        "2001–2007",
        "24 (24 LT)",
        "–",
        "–",
        "16",
        "18",
        "0",
        "1.8",
        "–",
        "79",
        "–",
        "–",
        "76",
        "–"
      ],
      [
        "Cheng, 200995",
        "China",
        "2001–2007",
        "36 (36 LRLT)",
        "–",
        "–",
        "32",
        "2",
        "2",
        "3.7",
        "–",
        "75",
        "–",
        "–",
        "75",
        "–"
      ],
      [
        "Yoshitoshi, 200996",
        "Japan",
        "1992–2006",
        "32 (32 LRLT)",
        "8",
        "24",
        "11",
        "21",
        "0",
        "6.7",
        "–",
        "84",
        "80",
        "–",
        "88a",
        "83a"
      ],
      [
        "Arnon‐(UNOS), 201168",
        "USA",
        "1987–2008",
        "570 (n/a)",
        "400",
        "170",
        "–",
        "",
        "",
        "–",
        "–",
        "89, ch",
        "–",
        "–",
        "",
        ""
      ],
      [
        "",
        "",
        "",
        "",
        "",
        "",
        "",
        "",
        "",
        "",
        "",
        "86, ad",
        "",
        "",
        "",
        ""
      ],
      [
        "Arnon‐(UNOS), 201168",
        "USA",
        "2002–2008",
        "170 (n/a)",
        "119",
        "51",
        "67",
        "103",
        "0",
        "–",
        "–",
        "100/88b, ch",
        "",
        "–",
        "100/82b, ch",
        ""
      ],
      [
        "90/90b, ad",
        "86/86b, ad"
      ],
      [
        "Guillaud, 201471",
        "France",
        "1985–2009",
        "121 (140 LT)",
        "75",
        "46",
        "55",
        "59",
        "7",
        "6",
        "–",
        "87",
        "87",
        "–",
        "80",
        "79"
      ],
      [
        "Ferrarese, 202097",
        "Italy",
        "2006–2016",
        "27 (27 LT)",
        "27",
        "0",
        "24",
        "1",
        "2",
        "–",
        "–",
        "88",
        "83",
        "–",
        "88",
        "82"
      ]
    ],
    "row_count": 15,
    "column_count": 9
  }
]